Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Adia MedADIA 14 Pretax Margin % is -92.61% as of Mar. 2026. GuruFocus rates ADIA with a GF Score™ of 14/100. The stock has 4 warning signs investors should review. Among 663 Healthcare Providers & Services companies, Adia Med ranks worse than 87.18% on this metric.
Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Adia Med's Pre-Tax Income for the
three
months ended in Mar. 2026 was $-0.16 Mil. Adia Med's Revenue for the
three
months ended in Mar. 2026 was $0.18 Mil. Therefore, Adia Med's pretax margin for the quarter that ended in Mar. 2026 was -92.61%.
The historical rank and industry rank for Adia Med's Pretax Margin % or its related term are showing as below:
ADIA'
s Pretax Margin % Range Over the Past 10 Years
Min: -3016.67 Med: -1536.51 Max: -56.35
Current: -58.57
ADIA's Pretax Margin % is ranked worse than 87.18% of 663
companies
in the Healthcare Providers & Services industry
Industry Median: 4.02
vs ADIA: -58.57
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Adia Med Pretax Margin % Related Terms
Adia Med Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Adia Med's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ADIA vs GBCS, CCM, CDIX: Pretax Margin % Comparison
For the Medical Care Facilities subindustry, Adia Med's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Adia Med Pretax Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Adia Med's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Adia Med's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Adia Med (ADIA) has a Pretax Margin % of -92.61% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Adia Med and its competitors. According to the industry distribution chart, Adia Med ranks #578 out of 663 companies in the Healthcare Providers & Services industry, placing it in the top 87.2%.
Is Adia Med's Pretax Margin % too high?
Adia Med's current Pretax Margin % is -92.61%. Based on the distribution chart, Adia Med ranks #578 out of 663 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Adia Med has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Adia Med's Pretax Margin % compare to GBCS and CCM?
According to the Healthcare Providers & Services industry distribution chart, Adia Med ranks #578 out of 663 companies for Pretax Margin %. This places Adia Med in the lower half of its industry. The industry median Pretax Margin % is 4.02. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Healthcare Providers & Services company?
The median Pretax Margin % among Healthcare Providers & Services companies is 4.02, based on 663 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Adia Med and its competitors. For the Healthcare Providers & Services industry, the median Pretax Margin % is 4.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Adia Med's current Pretax Margin % is -92.61%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adia Med stock overvalued right now?
Adia Med (ADIA) has a current Pretax Margin % of -92.61%. The current Pretax Margin % is -92.61%. Adia Med's overall GF Score™ is 14/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Adia Med (ADIA), the current Pretax Margin % is -92.61% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Adia Nutrition Inc focus is to work closely with healthcare providers and health insurance companies to facilitate and provide Autologous Hematopoietic Stem Cell Transplantation (AHSCT). Its products and the deployment of the therapies utilizing its products address various orthopedic issues, pain management, and wound repair. In addition, its products are able to be utilized in various other therapies to address anti-aging issues and other tissue repair desires. It operates in three segments The Biolete segment comprises the sale of supplements; Adia Med performs stem cell treatments to patients; and Adia Labs procures and sells stem cell products to outside clinics or to Adia Med. It derives revenue from Sales of supplements, Medical procedures, Sales of biologics and ancillary products.
14GF Score
Get the complete analysis for ADIA
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ADIA has been successfully added to your 
